No Data
No Data
Sage Therapeutics, Biogen End Licensing Agreement for Tremor Drug
Biogen to End Sage Deal for Neuro Candidate
Express News | Sage Therapeutics Inc - to Evaluate Other Potential Indications for Sage-324
Express News | Sage Therapeutics Inc - Termination Effective February 17, 2025; Sage to Resume Full Ownership of Sage-324
Express News | Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the Sage-324 Program
Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the SAGE-324 Program
No Data
No Data